Physicians can use the implant to treat anterior cruciate ligament tears, a first-of-its-kind technology. Before the implant, surgeons had to surgically reconstruct a patient’s ACL.
Although reconstruction restores function, a patient’s knee is never the same.
This implant restores natural anatomy and function of the knee and is also less invasive. The implant, notably, doesn’t require surgeons to remove a tendon like reconstruction does.
Miach Orthopaedics plans to release the BEAR Implant to market in 2021.
More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.